Clinical significance of acute neurohormonal response after levosimendan treatment.
Giannakoulas
George
G
Giannoglou
George
G
Vassilikos
Vasilis
V
Martiadou
Kostantina
K
Kalpidis
Panagiotis
P
Parharidis
George
G
Louridas
George
G
D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood / Q000378:metabolism*; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D015996:Survival Rate; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; D000077464:Simendan